期刊文献+

超声辐照微泡介导双自杀基因转染对乳腺癌杀伤作用的在体研究 被引量:4

Anti-tumor effect of suicide gene transfection mediated by microbubble-enhanced ultrasonic irradiation on breast cancer: an in vivo study
原文传递
导出
摘要 目的:探讨超声辐照微泡介导CD/TK双自杀基因质粒转染对在体乳腺癌的杀伤效应。方法:用人乳腺癌MCF-7细胞建立裸鼠移植瘤模型后,将荷瘤裸鼠随机分为对照组、质粒组、超声辐照组、超声辐照微泡组,每组5只。对照组仅给予CD与TK相应的前药(5-氟胞嘧啶与更昔洛韦);质粒组注射质粒(含CD/TK基因)与前药;超声辐照组注射质粒与前药,并予超声辐照;超声辐照微泡组注射靶向超声造影剂(质粒与微泡混合物)与前药,并予超声辐照。实验期间记录裸鼠肿瘤生长情况;处理结束后5 d,剥除肿瘤,计算各组的抑瘤率;用倒置荧光显微镜观察目的基因瘤内转染情况,计算基因转染效率;RT-PCR法检测目的基因的表达;免疫组化法计数肿瘤的微血管密度(MVD)。结果:与对照组比较,质粒组肿瘤的生长无统计学差异(P>0.05),而超声辐照组与超声辐照微泡组肿瘤生长被明显抑制(均P<0.05),质粒组、超声辐照组、超声辐照微泡组的抑瘤率分别为3.72%、21.40%、47.13%。质粒组、超声辐照组、超声辐照微泡组基因转染效率分别为0.78%、2.81%、23.87%,后者转染效率明显高于前两组(均P<0.05)。超声辐照组与超声辐照微泡组肿瘤组织中均出现CD/TK基因阳性片段,而对照组与质粒组的肿瘤组织中未见。超声辐照组与超声辐照微泡组肿瘤组织MVD计数均明显低于对照组,且超声辐照微泡组低于超声辐照组(均P<0.05),质粒组MVD计数与对照组无统计学差异(P>0.05)。结论:超声辐照微泡介导的双自杀基因系统能有效提高基因转染效率与表达,从而增强对肿瘤生长和肿瘤微血管的生成的抑制作用。 Objective:To investigate the anti-tumor effect of the transfection of plasmid containing CD/TK double suicide genes mediated by microbubble-enhanced ultrasound exposure on breast cancer in vivo.Methods:After the xenograft tumor model was created in nude mice using human breast cancer MCF-7 cells,the tumor-bearing mice were randomly divided into control group,plasmid group,ultrasonic irradiation group and ultrasonic irradiation plus microbubble agent group,with 5 mice in each group.Mice in control group were only given the corresponding CD and TK prodrugs(5-fluorocytosine and ganciclovir),mice in plasmid group were injected with the plasmids(containing CD/TK gene) and prodrugs,mice in ultrasonic irradiation group were injected with plasmids and prodrugs combined with ultrasonic irradiation,and those in ultrasonic irradiation plus microbubble agent group were injected with targeted ultrasonic contrast agent(mixture of plasmids and microbubble agent) combined with ultrasonic irradiation.The growth of the tumors was recorded during the experiment.After the tumors were enucleated at post-treatment day 5,the tumor inhibition rate in each group was calculated,the transfection of the target genes in the tumors was observed by an inverted fluorescence microscope,and the transfection efficiency was also analyzed;the expression of the target genes was determined by RT-PCR method;the microvessel density(MVD) of the tumors was detected by immunohistochemical staining.Results:Compared with control group,the tumor growth in plasmid group showed no obvious difference(P〉0.05),while in both ultrasonic irradiation group and ultrasonic irradiation with microbubble agent group it was significantly inhibited(both P〈0.05),and tumor inhibition rate in plasmid group,ultrasonic irradiation group and ultrasonic irradiation plus microbubble agent group was 3.72%,21.40%and 47.13%,respectively.The gene transfection efficiency in plasmid group,ultrasonic irradiation group and ultrasonic irradiation plus microbubble agent group was 0.78%,2.81%and 23.87%,respectively,which in the latter group was significantly higher than that in the former two groups(both P〈0.05).The positive DNA fragment of CD/TK gene was present in the tumors from the ultrasonic irradiation group or ultrasonic irradiation plus microbubble agent group,but was absent in those from control group and plasmid group.The MVD count in tumors from both ultrasonic irradiation group and ultrasonic irradiation plus microbubble agent group was significantly lower than that in control group(both P〈0.05),which in ultrasonic irradiation with microbubble agent group was even lower than that in ultrasonic irradiation group(both P〈0.05),but showed no statistical difference between plasmid group and control group(P〉0.05).Conclusion:The double suicide gene system mediated by microbubble-enhanced ultrasonic irradiation can effectively increase the transfection efficiency and expression of the target gene,and thereby exert an enhanced inhibitory effect on tumor growth and angiogenesis.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2014年第11期1487-1493,共7页 China Journal of General Surgery
基金 国家自然科学基金面上资助项目(81271680) 湖南省科学技术厅科技计划资助项目(2011SK3245)
关键词 乳腺肿瘤 基因疗法 疾病模型 动物 小鼠 Breast Neoplasms Gene Therapy Disease Models,Animal Mice,Nude
  • 相关文献

参考文献15

  • 1Bieche I, Tozlu S, Girauh I, et al. Identification of a three-gene expression signature of poor-prognosis breast carcinoma[J]. Mol Cancer, 2004, 3(1):37.
  • 2刘丽萍,王智彪.SonoVue^(TM)——一种新型超声对比剂的研究进展[J].国外医学(生物医学工程分册),2005,28(1):40-42. 被引量:13
  • 3Miller DL, Pislaru SV, Greenleaf JE. Sonoporation: mechanical DNA delivery by ultrasonic cavitation[J]. Somat Cell Mol Genet, 2002, 27(1-6):115-134.
  • 4Chen ZY, Sun XF, Liu JQ, et al. Augmentation of transgenic expression by uhrasound-mediated liposome microbubble destnctien[J]. Mol Med Rep, 2012, 5(4):964-970.
  • 5冉海涛,任红,王志刚,唐海林,凌智瑜,罗子国.超声波空化效应对体外培养细胞细胞膜作用的实验研究[J].中华超声影像学杂志,2003,12(8):499-501. 被引量:51
  • 6Portsmouth D, Hlavaty J, Rennet M. Suicide genes for cancer therapy[J]. Mol Aspects Med, 2007, 28(1):4-41.
  • 7Vargo-Gogola T, Rosen JM. Modelling breast cancer: one size does not fit all[J]. Nat Rev Cancer, 2007, 7(9):659-672.
  • 8Shoji M, Sun A, Kisiel W, et al. Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIla[J]. Drug Target, 2008, 16(3): 185-197.
  • 9汪朝霞,王志刚.超声微泡造影剂携基因或药物治疗研究[J].中国介入影像与治疗学,2006,3(4):306-308. 被引量:39
  • 10Alter J, Sennoga CA, Lopes DM, et al. Microbubble stability is a major delerminanl of the efficiency of ultrasound and microbubblemediated in vivo gene transfer [J]. Ultrasound Med Biol, 2009, 35(6):976-984.

二级参考文献31

  • 1周忠江,叶海燕,张新宇,查道刚,吴平生,刘伊丽.超声介导载基因微泡靶向传输血管内皮生长因子促心肌血管新生[J].中华心血管病杂志,2004,32(5):438-441. 被引量:7
  • 2张群霞,王志刚,冉海涛,彭晓琼,李晓东,彭明利,刘宪华,景香香,杨春江.超声微泡促进肿瘤细胞报告基因转染[J].临床超声医学杂志,2005,7(2):78-80. 被引量:17
  • 3张群霞,王志刚,冉海涛,孙建明,赵建农,郭大静,宋烈军.超声微泡介导VEGF基因治疗下肢血管闭塞[J].中国医学影像技术,2005,21(4):507-509. 被引量:12
  • 4Gorce JM, Arditi M, Schneider M. Influence of bubble size distribution on the echogenicity of ultrasound contrast agents: A study of SonoVue^TM[J]. Invest Radiol, 2000, 35: 661-671.
  • 5Schneider M, Broillet A, Areiti M, et al. Doppler intensitometry with BR1, a sonographic contrast agent[J]. Acad Radiol, 1996, 3: 308-311.
  • 6Morel D, Schwieger L, Hohn L, et al. Human pharmacokinetics and safety evaluation of SonoVue^TM, a new contrast agent for ultrasound imaging[J]. Invest Radiol, 2000, 35( 1 ): 80-85.
  • 7Soman P, Lahiri A, Senior R. Safety of an intravenous second generation contrast agent in patients with severe left ventriculars function[J].Heart, 2000, 84(6): 634-635.
  • 8Broillet A, Puginier J, Ventrone R, et al. Assessment of myocardial perfusion by intermittent harmonic power doppler using SonoVue^TM, anew ultrasound contrast agent[J]. Invest Radiol, 1998, 33(4): 209-215.
  • 9Bauer A, Solbiati L, Weissman N. Ultrasound imaging with SonoVue^TM.Low mechanical index real-time imaging [J]. Acad Radiol, 2002, 9(Suppl 2): 282-284.
  • 10Rovai D, Lubrano W, Vassale C, et al. Detection of myocardial perfusion deficits by intravenous administration of the ultrasonic contrast agent BRI[J]. Circ, 1995, 92: 1659-1662.

共引文献107

同被引文献29

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部